Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 953

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 10
Chunk 953
---
 of directors candidates for nomination for election at the annual general meeting of the shareholders. The board of directors will
also consider director candidates recommended for nomination by holders of our ordinary shares during such times as they are seeking proposed
nominees to stand for appointment at an annual general meeting (or, if applicable, an extraordinary general meeting). Our shareholders
that wish to nominate a director for election to the board of directors should follow the procedures set forth in our amended and restated
memorandum and articles of association.

We have not formally established any specific,
minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating
nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our
business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.

Clawback Policy

We have adopted a compensation recovery policy
that is compliant with Nasdaq listing rules as required by the Dodd-Frank Act.

Code of Conduct

We have adopted a Code of Conduct applicable to our directors, officers
and employees, which is available by accessing our public filings at the SEC’s website at www.sec.gov and on our website.
In addition, a copy of our Code of Conduct will be provided without charge upon request from us. We intend to disclose any amendments
to or waivers of certain provisions of our Code of Conduct in a Current Report on Form 8-K. 

Insider Trading Policy

We e have adopted an insider
trading policy and procedures governing the purchase, sale, and/or other dispositions of its securities by directors, officers and employees,
or the Company itself, that are reasonably designed to promote compliance with insider trading laws, rules and regulations, and any listing
standards applicable to the Company.

21

Section 16(a) Beneficial Ownership Reporting
Compliance

Section 16(a) of the Exchange
Act requires our executive officers, directors and persons who beneficially own more than 10% of a registered class of our equity securities
to file with the SEC initial reports of ownership and reports of changes in ownership of our shares of common stock and other equity securities.
These executive officers, directors, and greater than 10% beneficial owners are required by SEC regulation to furnish us with copies of
all Section 16(a) forms filed by such reporting persons.

Based solely on our review of
such forms furnished to us and written representations from certain reporting persons, we